the next step is banning PBMs from owning pharmacies.
Ban pharmacy benefit managers from owning pharmacies.
Occurrences
introduced the Pharmacists Fight Back Act to tackle the manipulative practices of Pharmacy Benefit Managers (PBMs) - the middlemen of drug pricing.
introduced the Community Health Center Drug Pricing Protection Act to exempt Community Health Centers (CHCs) and Federally Qualified Health Centers (FQHC) from the Trump administration’s proposed 340B Rebate Model Pilot Program.
Mrs. Harshbarger (for herself and Mr. Auchincloss) introduced the following bill... To prohibit pharmacy benefit managers and pharmacies from being under common ownership... It shall be unlawful for any person to both... own, operate, control, or direct the operation of the whole or any part of a pharmacy; and... own, operate, or control... a pharmacy benefit manager.
Evidence
Representatives Jake Auchincloss and Diana Harshbarger, alongside Senators Elizabeth Warren and Josh Hawley, reintroduced the Patients Before Monopolies (PBM) Act with expanded bipartisan support to rein in drug pricing middlemen, known as pharmacy benefit managers (PBMs), from enriching themselves and crushing competition at the expense of patients and independent pharmacies.
Sponsor: Sen. Warren, Elizabeth [D-MA] (Introduced 02/10/2026). Latest Action: Senate - 02/10/2026 Read twice and referred to the Committee on the Judiciary. Tracker: This bill has the status Introduced. Official Title as Introduced: A bill to prohibit pharmacy benefit managers, insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers, and for other purposes.
To prohibit pharmacy benefit managers and pharmacies from being under common ownership, and for other purposes.
As of the June 18, 2026 review, Congress.gov still shows S.3822 as introduced on February 10, 2026 and referred to the Senate Judiciary Committee, with no later actions, floor passage, or enactment listed.
Representatives Jake Auchincloss and Diana Harshbarger, alongside Senators Elizabeth Warren and Josh Hawley, reintroduced the Patients Before Monopolies Act. The release says the bill would prohibit a parent company of a PBM or insurer from owning a pharmacy business and require divestment within one year of enactment.
Auchincloss's official legislation page lists H.R.8779 as cosponsored, updated 05/13/26, with the description: To prohibit pharmacy benefit managers and pharmacies from being under common ownership, and for other purposes.
Congress.gov lists S.3822 as introduced on 02/10/2026, referred to the Senate Judiciary Committee, with the tracker status Introduced. Its official title is a bill to prohibit PBMs, insurers, and prescription drug or medical device wholesalers from common ownership with certain medical service providers.
Congress.gov lists H.R.10362 as introduced on 12/11/2024, referred to the House Judiciary Committee, with status Introduced. The page lists Rep. Jake Auchincloss as an original cosponsor and gives the official title as prohibiting pharmacy benefit managers and pharmacies from being under common ownership.
The introduced bill text says Mrs. Harshbarger, for herself and Mr. Auchincloss, introduced the bill. It states that it would be unlawful for a person to own or control a pharmacy and also own or control an insurance company or pharmacy benefit manager, with divestment required after enactment.
Congress.gov lists S.5503 as sponsored by Sen. Elizabeth Warren, introduced 12/12/2024, read twice and referred to the Senate Judiciary Committee. The tracker status is Introduced.
The S.5503 text says the bill would prohibit pharmacy benefit managers and pharmacies from common ownership. It provides that it would be unlawful for a person to own or control a pharmacy and also own or control an insurance company or pharmacy benefit manager, and requires divestment within three years after enactment.
Assessments
The promised outcome requires an enacted federal ban on PBM-pharmacy common ownership. Auchincloss materially advanced legislation matching the promise, including the PBM Act/Patients Before Monopolies Act, and the bill text would prohibit common ownership and require divestment. But the relevant House and Senate vehicles remained introduced or referred to committee and had not become law as of the current review, so the substantive ban was not delivered. Because he made a serious legislative attempt, effort credit applies.
Auchincloss took a serious legislative step by reintroducing and backing the PBM Act, which directly matches the promise to bar pharmacy benefit managers from owning pharmacies. But the relevant federal proposal remained only introduced and referred to committee, with no floor passage or enactment as of June 18, 2026. Under a federal-office standard, sponsorship and advocacy show meaningful effort, but without enacted law or implemented policy the promised outcome was not delivered.
Auchincloss materially advanced the promised policy by introducing or reintroducing federal legislation to prohibit common ownership between PBMs and pharmacies, matching the substance of the promise. However, the evidence shows the 119th Congress bill was only introduced and referred to committee, and no enactment or implemented federal ban is shown. Because there was a serious legislative attempt but the promised ownership ban has not been delivered, this should be scored as not fulfilled with an effort badge.